Patients Dramatically Reduce Their Opioid Use Following Cannabis Access

MMJ reduces opioid use

CANADA: Pain patients enrolled in Canada’s legal medical cannabis access program significantly reduce their use of opioids over the long-term, according to longitudinal data provided by Tilray Canada Ltd - one of the nation’s largest, licensed provider of medicinal marijuana products. Investigators assessed opioid use patterns in a cohort of 573 patients using Tilray-provided products. Among those patients who acknowledged Read the full article…

Patients Use Fewer Opioids Following Enrollment In Medical Cannabis Program

The study's findings are similar to those reported among enrollees in other states' medical cannabis programs, including the experiences of patients in Illinois, Michigan, Minnesota, New Mexico, and elsewhere.

NEW YORK:  Patients enrolled in New York state’s medical cannabis program reduce their use of opioids and spend less money on prescription medications, according to data published online in the journal Mental Health Clinician. Investigators from GPI Clinical Research labs in Rochester and the University of Buffalo assessed trends in patients’ medical cannabis and prescription drug use following Read the full article…